Display options
Share it on

Endocrine. 2004 Mar-Apr;23(2):119-23. doi: 10.1385/ENDO:23:2-3:119.

Causes of erectile dysfunction.

Endocrine

Jeremy P W Heaton, Michael A Adams

Affiliations

  1. Departments of Urology and Pharmacology and Toxicology, Queen's University, 76 Stuart Street, Kingston, Ontario, Canada. [email protected]

PMID: 15146089 DOI: 10.1385/ENDO:23:2-3:119

Abstract

Erectile dysfunction (ED) arises as a result of a collision of circumstances among any of a number of factors (e.g., risk factors, causes, probable associations), each with its own primary power to affect the outcome. Furthermore, each of the components has its own timing as part of a complex effort of compensation and adjustment that often obscures the individual details. In the end, ED results from a failure of local tissues or systemic supply and control structures. The power of any individual "cause" to degrade erectile function is an important but as-yet unquantified property. The power of a small abnormality over a long or critical period (e.g., organogenesis), or many small contributions, or multiple risk factors will certainly be greater than the sum of the individual elements. Without a full quantitation of pathways and their potential influence, one can compare the importance of causative factors only in limited ways. Not surprisingly, it is the presence of a multiplicity of unidentified or poorly understood causative factors that accounts in large measure for the current inability to cure and prevent ED. There are two other important properties of a putatively causative factor for ED--reversibility and preventability--and these are strongly influenced by the time of onset and the duration of impact. Thus, a critical understanding that comes from recognizing the importance of the temporal associations of component factors is that the causes of ED in an individual may be guessed at but cannot be fully disclosed by an analysis of a "snapshot" of the disease taken at the time of diagnosis.

Copyright 2004 Humana Press Inc.

References

  1. Neurosci Biobehav Rev. 2000 Jul;24(5):571-9 - PubMed
  2. Eur J Vasc Endovasc Surg. 1996 May;11(4):453-7 - PubMed
  3. Curr Opin Investig Drugs. 2002 Oct;3(10):1489-95 - PubMed
  4. J Androl. 2002 Sep-Oct;23(5):S20-6 - PubMed
  5. Int J Urol. 1999 Jan;6(1):19-23 - PubMed
  6. Curr Urol Rep. 2001 Dec;2(6):463-7 - PubMed
  7. Gerontology. 2000 Nov-Dec;46(6):295-9 - PubMed
  8. J R Soc Promot Health. 1998 Jun;118(3):151-5 - PubMed
  9. Int J Impot Res. 2001 Dec;13 Suppl 5:S29-34 - PubMed
  10. J Hypertens. 1995 Dec;13(12 Pt 2):1508-21 - PubMed
  11. Int J Impot Res. 2002 Dec;14(6):433-9 - PubMed
  12. Heart. 2003 Mar;89(3):251-3 - PubMed
  13. J Mol Cell Cardiol. 2001 Sep;33(9):1673-90 - PubMed
  14. J Urol. 2001 Aug;166(2):734-8 - PubMed
  15. Urology. 2000 Aug 1;56(2):302-6 - PubMed
  16. Int J Impot Res. 2002 Oct;14(5):361-74 - PubMed
  17. Urol Clin North Am. 2003 Feb;30(1):73-81 - PubMed
  18. Diabetes Metab. 2001 Sep;27(4 Pt 1):425-34 - PubMed
  19. Urol Clin North Am. 2001 May;28(2):217-31, vii - PubMed
  20. Ann N Y Acad Sci. 2001 Dec;947:199-205; discussion 205-6 - PubMed
  21. Curr Urol Rep. 2001 Dec;2(6):488-94 - PubMed
  22. Int J Impot Res. 1997 Jun;9(2):85-91 - PubMed
  23. J Urol. 2001 Nov;166(5):1624-32 - PubMed
  24. Hypertension. 1997 Jan;29(1 Pt 1):8-14 - PubMed
  25. Int J Impot Res. 2003 Feb;15(1):72-8 - PubMed
  26. Invest Urol. 1977 Nov;15(3):194-9 - PubMed
  27. Int J Impot Res. 2002 Feb;14 Suppl 1:S17-21 - PubMed
  28. J Urol. 2000 Feb;163(2):460-3 - PubMed
  29. Expert Opin Pharmacother. 2002 Jul;3(7):889-97 - PubMed
  30. Am J Hypertens. 2002 Oct;15(10 Pt 2):115S-122S - PubMed
  31. Urology. 2002 Sep;60(2 Suppl 2):4-11 - PubMed
  32. Eur Urol. 1994;25(2):142-4 - PubMed
  33. BJU Int. 2001 Mar;87(4):402-7 - PubMed
  34. Annu Rev Sex Res. 1999;10:157-83 - PubMed
  35. Int J Impot Res. 2000 Oct;12 Suppl 4:S26-33 - PubMed
  36. Atherosclerosis. 2002 Jun;162(2):355-62 - PubMed
  37. World J Urol. 1997;15(1):27-31 - PubMed
  38. J Pathol. 2003 Jan;199(1):8-17 - PubMed
  39. Urology. 2003 Jan;61(1):201-6 - PubMed
  40. J Urol. 2002 Jul;168(1):348-54 - PubMed
  41. Pharmacol Rev. 2001 Sep;53(3):417-50 - PubMed
  42. J Urol. 1994 Jan;151(1):54-61 - PubMed
  43. Endocrine. 2003 Feb-Mar;20(1-2):75-82 - PubMed
  44. Int J Impot Res. 2002 Feb;14 Suppl 1:S6-10 - PubMed
  45. Int J Exp Pathol. 2000 Aug;81(4):219-30 - PubMed
  46. Vasc Med. 2002 Aug;7(3):213-25 - PubMed
  47. Microcirculation. 2000 Dec;7(6 Pt 1):367-84 - PubMed

MeSH terms

Publication Types